Marketing your medspa's GLP-1 or semaglutide program post-FDA crackdown? Here's how to market compliantly, capture high-intent patients, and build the most profitable program in your practice.

You added GLP-1 to your medspa and it was supposed to be a game-changer. And it still can be — but somewhere between the FDA’s February 2025 compounding crackdown, Google’s drug advertising policies, and Instagram removing posts faster than you can blink, marketing your program started feeling like walking through a minefield.

You are not alone. Every medspa owner who added semaglutide or tirzepatide in the last 18 months is wrestling with the same question: *how do I grow this program without getting flagged, fined, or burned?*

This guide gives you a straight answer. No vague disclaimers. No hedging. Just the compliance-first marketing strategy that Sprout Sage has built for 65+ medspas navigating exactly this landscape.

—

Why GLP-1 Marketing Is Different (And Why Most Medspas Get It Wrong)

Most medspa marketing follows a simple formula: show the result, name the treatment, run the ad. With GLP-1 programs, that formula gets you into trouble. Fast.

What Changed in February 2025

In February 2025, the FDA ended the shortage designation for semaglutide and tirzepatide. That single policy decision pulled the legal ground out from under the entire compounded GLP-1 market. Under the shortage designation, 503A and 503B compounding pharmacies had been permitted to compound copies of shortage drugs. Once the shortage designation was lifted, that exemption evaporated.

The practical consequence: medspas that had been dispensing or prescribing compounded semaglutide or tirzepatide were operating in a gray zone that had just turned red. The FDA sent warning letters. State medical boards followed. Some practices pivoted overnight. Others did not move fast enough.

If your practice is still sourcing compounded semaglutide as of mid-2026, you need a conversation with a healthcare attorney before you run another ad.

What Medspas Can Still Do — Legitimately

The end of compounding is not the end of your GLP-1 program. Here is what remains fully viable:

• Prescribing FDA-approved branded medications: Ozempic, Wegovy, Mounjaro, and Zepbound are all still prescribable by licensed practitioners. Your program can be built around these.
• Medical weight loss programs with pharmaceutical support: The program itself — consultation, monitoring, nutrition coaching, body composition tracking — is entirely marketable. The drug is just one component.
• Lifestyle and wellness programs that complement GLP-1 therapy: nutrition plans, fitness protocols, accountability check-ins.
• Body contouring as a complement: This is where medspa-specific GLP-1 marketing becomes a genuine revenue category. More on this below.

The Compliance Minefield in Plain English

The three areas where medspas most commonly make costly mistakes:

1. Claiming to prescribe or “provide” a specific drug in advertising You are not a pharmacy. Saying “we offer semaglutide injections” in a Google Ad is treated differently than saying “medically supervised weight loss program.” The first can trigger policy violations or worse. The second is clean.

2. Before-and-after imagery tied to weight loss Meta and Instagram prohibit before-and-after images in weight loss advertising contexts. Scale photos, measurement photos, and explicit body comparison images regularly get ads rejected and accounts flagged.

3. Pricing a drug in the same message Listing a drug name alongside a dollar amount in any patient-facing communication — email, SMS, social post — is a pattern regulators and platforms flag as direct drug promotion. Separate the program cost from the medication conversation.

Know the lines. Stay comfortably behind them.

—

The GLP-1 Patient Profile in 2026

Before you run a single ad or write a single service page, you need to understand exactly who you are talking to. The GLP-1 patient who books at a medspa is not the same person who downloads a telehealth app.

Who They Are

Your core GLP-1 patient demographic skews 35–65, with the highest converting segment in the 42–58 range. They have real disposable income — household income of $100K+ in most markets. Critically, many of them are already your patients or former patients. They have gotten Botox from you. They have done laser treatments. They trust you, they know where you are, and they are not looking to hand their health to an algorithm.

They have often tried other approaches — weight loss programs, apps, even telehealth prescribers — and they came back wanting something more accountable, more personal, more supervised.

What They Actually Want

They are not just looking for a drug. They are looking for a program. The distinction matters enormously for how you position and market your offering.

They want:

• A licensed provider who knows their history and adjusts their protocol
• Regular check-ins — not just a prescription renewal portal
• Someone to call when side effects hit in week three
• A path to body composition improvement, not just a number on a scale
• To look as good as they are going to feel

This is why medspas outperform telehealth platforms for retention in GLP-1 programs. You can deliver all of the above. A telehealth startup cannot.

How They Search

Understanding search behavior lets you place your content exactly where intent is highest. Your GLP-1 prospects are searching for:

• “GLP-1 near me” / “GLP-1 clinic [city]”
• “semaglutide [city]” / “semaglutide injections [city]”
• “medical weight loss program [city]”
• “Ozempic near me” / “Wegovy clinic”
• “supervised weight loss program”
• “GLP-1 vs phentermine”
• “semaglutide side effects” / “how to manage GLP-1 side effects”
• “weight loss and body contouring”
• “GLP-1 skin laxity treatment”

Each of these search queries represents a different stage of the decision journey. Your content and ad strategy needs to cover them all.

—

The 3-Phase GLP-1 Marketing Strategy

A compliant, high-performing GLP-1 marketing strategy for a medspa operates across three interlocking phases. You need all three. Running only one or two is why most practices plateau.

—

Phase 1: Organic / SEO — Own Your Local Search Category

The medspa that ranks for GLP-1 searches in your market owns that category for years. Most of your competitors are not doing this work. The window to establish first-mover authority is right now.

Service Page Optimization

Your GLP-1 service page is the single most important piece of content you will create for this program. It needs to:

• Lead with the program outcome, not the drug name
• Explain what medical supervision means in your practice
• Cover what branded FDA-approved medications are available
• Describe what a patient can expect from their first consultation through ongoing monitoring
• Include a clear, prominent call to action for booking a consultation

Target the page for terms like “medical weight loss program [city],” “GLP-1 weight loss clinic [city],” and “supervised weight loss [city].” Avoid building your page around “compounded semaglutide” — that ship has sailed, and chasing those terms now attracts the wrong regulatory attention.

Location Pages for Surrounding Areas

If you serve patients from multiple cities or suburbs, build individual location-optimized pages for each. “Semaglutide clinic [suburb]” queries are lower competition and convert at high rates because the searcher’s intent is explicit.

Supporting Content Cluster

A single service page is not an SEO strategy. Build a content cluster that captures patients at every stage of the research journey:

• “GLP-1 vs. Phentermine: What’s the Difference?” — captures comparison-stage searchers
• “Managing GLP-1 Side Effects: What Your Medical Team Wants You to Know” — builds trust and captures side effect query traffic
• “What to Expect From a Medical Weight Loss Program: Month by Month” — pre-qualifies patients and reduces no-show rates
• “GLP-1 and Body Contouring: Why Skin Tightening Belongs in Your Weight Loss Plan” — this content is uniquely yours as a medspa and is completely uncontested territory
• “How to Choose a GLP-1 Provider: What to Look For” — captures bottom-of-funnel, high-intent patients who are comparison shopping

Each piece should link back to your service page. Together they signal to Google that your site is the authority on medical weight loss in your market.

—

Phase 2: Google Ads — Compliant, High-Intent Campaigns

Google Ads can drive immediate patient bookings for your GLP-1 program. But the platform’s healthcare advertising policies require precise execution. Getting this wrong means disapproved ads and potentially a suspended account.

What Google Allows

Google does not allow ads that advertise prescription drugs directly to consumers without certification, or that imply a drug can be purchased through the ad. However, Google absolutely allows:

• Ads for medical clinics and healthcare providers
• Ads for weight loss programs and wellness services
• Ads that lead to a consultation or intake process
• Local service-based ads for medical practices

The framing is everything. “Medical weight loss program — book your consultation” is compliant. “Buy semaglutide online — $200/month” is not.

Safe Keyword Strategy

Your highest-performing, lowest-risk keyword clusters for GLP-1 Google Ads:

*High-intent branded terms (compliant with correct landing page):*

• “Ozempic near me”
• “Wegovy clinic”
• “medical weight loss semaglutide”
• “GLP-1 weight loss program”

*Symptom and need-based terms:*

• “medically supervised weight loss [city]”
• “weight loss doctor [city]”
• “medical weight loss clinic [city]”
• “supervised weight loss program near me”

*Medspa-specific crossover terms:*

• “weight loss and body contouring”
• “medical weight loss medspa”

What Triggers Policy Violations

Avoid these in ad copy and on landing pages linked from ads:

• Implying compounded versions of medications are available
• Naming a drug and a price in the same ad
• Claims like “FDA-approved injections available” (too close to drug dispensing language)
• Any language that implies the patient will receive a prescription via the ad process

Your landing page must match your ad’s intent. If your ad says “book a weight loss consultation,” your landing page should be a consultation booking page — not a product page that lists drug options and prices.

Campaign Structure

Run separate campaigns for:

1. Branded medication terms (Ozempic, Wegovy, Mounjaro) — with compliant messaging
2. Generic medical weight loss terms — broader reach, lower cost per click
3. Body contouring crossover terms — your medspa differentiator

Set geographic radius targeting to your actual service area plus any high-value surrounding zip codes. GLP-1 patients will travel 20–30 minutes for a practice they trust.

—

Phase 3: The Package Strategy — The Real Revenue Play

This is where your GLP-1 program goes from a good add-on to a practice-defining profit center.

The math is simple but the implications are significant:

• Average contract value of a GLP-1-only patient: ~$400/month
• Average contract value of a GLP-1 package patient: ~$850/month

The difference is not that the package patient is spending frivolously. The difference is that you solved a problem they were already going to have — and you solved it before they went looking elsewhere.

GLP-1 + Body Contouring Bundle

Skin laxity is the number-one aesthetic concern among GLP-1 patients. As weight drops, skin doesn’t always follow. Your patients know this — they’re worried about it before they even start the program. You can address it directly.

Build a bundle that includes GLP-1 program enrollment alongside a predetermined number of body contouring sessions — RF microneedling, ultrasound therapy, or whatever your device mix supports. Package it as the “complete transformation program” rather than two separate services.

This bundle is uniquely yours to offer. A telehealth app cannot do this. Your family physician cannot do this. You are the only provider who can give patients the weight loss program and the body composition result in the same practice, with the same team.

GLP-1 + Vitamin IV/IM Injections

GLP-1 medications reduce appetite significantly, which means most patients are under-consuming key nutrients — B vitamins, magnesium, zinc, and protein in particular. Fatigue, brain fog, and muscle loss are common complaints in months two through five.

An IV nutrition or IM injection add-on solves this directly and improves patient satisfaction and retention. Offer it as part of an onboarding protocol, then as a monthly maintenance option.

This is clean, defensible marketing: “Our program includes nutritional support to help you feel your best while you lose weight.” No compliance issues. High perceived value. Genuine patient benefit.

GLP-1 Membership Program

The membership model converts your GLP-1 program from a transactional service into a recurring revenue stream with genuine retention mechanics.

A $299/month all-inclusive membership might include:

• Monthly provider consultation
• Monthly body composition scan
• Monthly IV or IM injection
• Access to your patient portal and progress tracking
• Priority booking for body contouring treatments
• Prescription management support (coordinate with prescriber or in-house if your licensing supports it)

The membership framing does several things at once: it pre-empts cancellation conversations by creating a sense of ongoing commitment, it increases touchpoints and therefore retention, and it makes the monthly cost feel like a program investment rather than a recurring charge.

Market the membership as “your complete weight management program” — not as a drug subscription. The distinction keeps you compliant and actually positions your offering more favorably.

—

Compliance Checklist: What to Say and What to Avoid

Use this table as your go-to reference before publishing any content, running any ad, or sending any patient communication related to your GLP-1 program.

When in doubt: describe the program, not the drug. Describe the outcome, not the substance. Focus on the supervision, the personalization, and the results. That is both the compliant path and the better marketing position.

—

Patient Retention: The GLP-1 Lifecycle

Acquiring a GLP-1 patient is expensive. Keeping them is where the program becomes profitable. Most medspas invest heavily in acquisition and almost nothing in retention — and then wonder why their program doesn’t scale.

Month 1–3: Highest Churn Risk

The first three months are when patients are most likely to quit. The reasons are predictable:

• Side effects (nausea, fatigue, GI issues) hit in weeks two through six
• The initial rapid weight loss slows, creating a psychological plateau effect
• The novelty wears off and the commitment feels harder
• Telehealth competitors are aggressively remarketing to your patients at lower price points

Your retention strategy for this window:

• Weekly touchpoints: A brief check-in message, progress acknowledgment, or coaching tip keeps patients engaged without requiring a full appointment. Automate this with a simple CRM sequence, but personalize the tone.
• Proactive side effect management: Send a “Week 3 Guide” that normalizes common side effects and gives patients a clear protocol for managing them. This dramatically reduces early dropout driven by side effect fear.
• Progress tracking that isn’t just a scale: Body composition measurements, energy levels, NSV (non-scale victories) like improved sleep or reduced joint pain — these keep patients motivated through the weight loss plateau.
• Community touchpoints: A private patient group (Facebook Group or even a simple Slack channel) creates peer accountability and dramatically improves retention. It takes 20 minutes to set up and costs nothing.

Month 4–5: The Body Contouring Upsell Moment

This is the window you have been waiting for. By month four to five, most patients have lost meaningful weight. They are proud of the results. They are also starting to notice skin laxity, particularly in the abdomen, arms, and thighs.

This is the natural, patient-driven moment to introduce body contouring. Do not wait for them to ask. Proactively schedule a body composition consultation at the month four check-in and include an aesthetic assessment as part of the protocol.

Frame it as: “Now that we’re seeing the weight come off, let’s make sure your body composition and skin reflect all the work you’ve put in.”

This is not an upsell. It is clinical continuity. Patients experience it as care, not as a sales pitch — because it genuinely is care.

The GLP-1 Graduation Program

Not every GLP-1 patient needs to be on medication indefinitely. Some will reach their goal weight and want to transition off. Rather than treating this as a patient departure, build a deliberate “GLP-1 graduation” pathway:

• A structured taper protocol
• A maintenance membership at a lower price point ($149/month) that includes quarterly check-ins, ongoing body composition tracking, and priority booking for maintenance body contouring
• A formal “graduation consultation” that celebrates the result and sets the maintenance plan

This turns a potential churn event into a membership conversion. Patients who “graduate” from your GLP-1 program and stay on a maintenance membership are among the most loyal and highest-referring patients in your practice. They have been through something significant with your team. They trust you completely.

—

How Sprout Sage Helps Medspas With GLP-1 Marketing

We work with 65+ medspas across the country, and GLP-1 has become one of the most common programs we build marketing infrastructure around. Here is exactly what that looks like:

Compliance-Reviewed Service Pages We build your GLP-1 service page with both SEO and compliance in mind — meaning it ranks for the searches that matter while staying clearly within FDA and platform advertising guidelines. No vague disclaimers. No boilerplate. Content that actually converts visitors into consultation bookings.

City-Specific Keyword Research GLP-1 search volume and competition varies significantly by market. A strategy that works in Dallas looks different from one that works in Phoenix or Nashville. We pull the exact keyword data for your city and build your content and ad strategy around what your specific patients are actually searching.

Google Ads Campaigns That Pass Policy Review We have run GLP-1 campaigns through Google’s healthcare advertising policies enough times to know exactly what language, landing page structure, and account configuration gets approved and stays approved. No guesswork, no suspended accounts, no wasted budget on disapproved ads.

Email Sequences for Patient Retention and Upsell The lifecycle sequences that move patients from month one to month six — including the side effect management series, the body contouring bridge sequence, and the graduation-to-maintenance conversion — are all done for you. We write, configure, and deploy them in your CRM.

No contracts. No lock-in. We work with medspas that want to build something real, not sign a 12-month retainer for a service they may not need indefinitely.

—

The Window Is Now

The medspas that dominate GLP-1 search in their markets over the next 12 months will be the ones that moved in 2026. The category is real, the patient demand is sustained, and the compliance framework is now clear enough that you can build on it with confidence.

Your competitors are scared to market this program. That is your opportunity.

If you want a GLP-1 marketing strategy built specifically for your market, your licensing setup, and your existing patient base, book a call with our team. We will walk through your current program, identify your highest-leverage opportunities, and show you exactly what a compliant, high-converting GLP-1 marketing system looks like for your practice.

Book a Strategy Call

Or call directly: +91 97297 12388

No pitch decks. No contracts. Just a straight conversation about what’s actually working for medspas in your category right now.

—

*Sprout Sage Solutions is a medspa-focused marketing agency. We do not provide legal or medical compliance advice. All marketing strategies should be reviewed by a licensed healthcare attorney familiar with your state’s medical advertising regulations.*